Monkeypox Update: FDA Authorizes Emergency Use of Jynneos Vaccine to Increase Vaccine Supply

August 09, 2022 -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Jynneos vaccine to allow healthcare providers to use the vaccine by intradermal injection for individuals 18 years of age and older...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials